Small-molecule allosteric inhibitors of BAX

Area of Science:

• Molecular biology
• Biochemistry
• Pharmacology

Background:

• BAX protein is central to the mitochondrial cell death pathway.
• BAX activation leads to mitochondrial outer-membrane permeabilization, a key event in apoptosis.
• Targeting BAX for therapeutic inhibition has been challenging.

Purpose of the Study:

• To identify and characterize novel small-molecule inhibitors of BAX.
• To elucidate the mechanism of action for these BAX inhibitors.
• To establish a new paradigm for targeting BAX-mediated cell death.

Main Methods:

• Screening for small-molecule BAX inhibitors (BAIs).
• Biochemical assays to assess BAI binding and allosteric inhibition of BAX activation.
• Analysis of BAX conformational changes, mitochondrial translocation, and oligomerization.

Main Results:

• A novel class of small-molecule BAX inhibitors (BAIs) was identified.
• BAIs bind to a previously unrecognized pocket on BAX, stabilizing its hydrophobic core.
• BAI binding allosterically inhibits BAX activation, preventing mitochondrial translocation and oligomerization.

Conclusions:

• BAIs represent a novel class of BAX inhibitors with a unique allosteric mechanism.
• Targeting this newly identified pocket offers a promising strategy for developing BAX-specific therapeutics.
• This work provides a new paradigm for the rational development of inhibitors for BAX-mediated cell death.